作者: Elliott N. Schwartz , Dee M. Steinberg
DOI: 10.1007/S11914-996-0023-4
关键词:
摘要: Clinical decision rules (CDRs) are designed to help physicians practice better. A number of CDRs assist in identifying women with low bone mass have been developed since the mid 1990s, including SCORE, OST (OSTA), OSIRIS, SOFSURF, NOF, ABONE, pBW, ORAI, and weight-only-EPIDOS (which we termed WO-E). This review discusses these terms development validation cohorts their sensitivity specificity. The sensitivities available exceed 80% specificities about 50%. After much analysis, it appears that most experts prefer for its simplicity SCORE flexibility, but there is no consensus on what risk factors use regions interest (spine, total hip, femoral neck, or a combination) test dual-energy x-ray absorptiometry (DXA). Because lack consensus, barriers clinical application CDRs. Agreement single CDR worldwide required optimally fulfill objective mass.